Browse the corpus

The volume of distribution (Vd) is a pharmacokinetic parameter that describes a drug's tendency to remain in the plasma or distribute into other tissue compartments. By definition, Vd is a proportionality constant that relates the total amount of drug in the body to the plasma concentration of the drug at a given time.[1][2][3] Volume of distribution is represented as: Vd=Amount of drug in the body/Plasma concentration of the drug. The unit of Vd is liter (L). In this relationship, the amount of drug in the body is typically expressed in milligrams (mg), and the plasma drug concentration is expressed in mg/L. Vd is a theoretical or apparent volume of fluid that a drug would need to occupy to achieve the observed plasma concentration. Traditionally, Vd is described in terms of the relationship between the drug’s plasma concentration and the total amount of drug in the body. Vd can vary depending on the dosing regimen and the timing of measurement.[3][4][5] Notably, Vd does not represent a true physical or physiological volume. Instead, it is an apparent or theoretical volume required to contain the total amount of drug in the body at the same concentration as measured in plasma.[6] Table Table 1. Types of Volume of Distribution. Abbreviations: Css=steady-state conditions; Vd=volume of distribution. Significance of Volume of Distribution A drug with a high Vd tends to leave the plasma and distribute extensively into extravascular compartments. Consequently, a higher dose may be required to achieve a given plasma concentration. (High Vd → Greater distribution into other tissues.) In contrast, a drug with a low Vd tends to remain in plasma, implying that a lower dose is required to achieve a given plasma concentration. (Low Vd → Less distribution into other tissues.) The volume of distribution is commonly determined using the drug concentration measured in plasma or serum, which are generally considered equivalent for this purpose.[7] Drugs can have variable Vd (eg, warfarin has a very low Vd [0.14 L/kg], whereas chloroquine has a high Vd [235 L/kg]).[1] Vd is commonly expressed in liters (L). However, it is often normalized to an individual’s body weight by dividing by body weight in kilograms (kg), resulting in a standardized unit of liters per kilogram (L/kg). Table Table 2. Comparison of Drugs With Low Versus High Volume of Distribution and Their Clinical Implications.

Vd is commonly expressed in liters (L). However, it is often normalized to an individual’s body weight by dividing by body weight in kilograms (kg), resulting in a standardized unit of liters per kilogram (L/kg). Table Table 2. Comparison of Drugs With Low Versus High Volume of Distribution and Their Clinical Implications. Abbreviations: ABW=adjusted body weight; AGS=American Geriatrics Society; AKI=acute kidney injury; Cp=target plasma concentration; ECF=extracellular fluid; EXTRIP=Extracorporeal Treatments in Poisoning; IBW=ideal body weight; IV=intravenous; KDIGO=Kidney Disease: Improving Global Outcomes; LD=loading dose; PPB=plasma protein binding; TDM=therapeutic drug monitoring; Vd=volume of distribution.

Understanding that Vd is a proportionality constant that can yield different values depending on the drug concentration measured at a specific time in the body is important for clinical practice. This concept is relevant for the interprofessional healthcare team, including clinicians, intensivists, neonatologists, anesthesiologists, pharmacologists, and nurses, when prescribing, monitoring, or administering medications through any route of administration.[55] Population pharmacokinetic models have been developed for several medications, including risperidone and paliperidone, providing detailed descriptions of their absorption, metabolism, and elimination. Future research should focus on the external validation of these models to facilitate their integration into clinical practice and support individualized dosing, ultimately improving treatment efficacy and safety across diverse patient populations.[56] Similarly, various other computational models have been developed to optimize individualized therapy with antimicrobials such as tigecycline and ampicillin-sulbactam.[57][58] Similarly, computational models have recently been developed across various therapeutic domains, including atogepant for migraine prophylaxis and tofacitinib for the treatment of active ankylosing spondylitis.[59][60] The concept of Vd was first formalized in classical pharmacokinetic modeling and remains one of the most widely used parameters in clinical pharmacy practice. This is of paramount importance for calculating loading doses, estimating drug half-life, and interpreting plasma drug concentrations during TDM. The ASHP and the ACCP recognize the clinical utility of Vd in both acute care and ambulatory pharmacy practice settings.[4][61] American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacokinetic monitoring. Am J Health Syst Pharm. 1998;55:1726-1727. Available at: https://www.ashp.org. Accessed February 17, 2026.American College of Clinical Pharmacology. Clinical pharmacology practice guidelines and position papers. Available at: https://www.accp1.org. Accessed February 17, 2026.

The concept of Vd was first formalized in classical pharmacokinetic modeling and remains one of the most widely used parameters in clinical pharmacy practice. This is of paramount importance for calculating loading doses, estimating drug half-life, and interpreting plasma drug concentrations during TDM. The ASHP and the ACCP recognize the clinical utility of Vd in both acute care and ambulatory pharmacy practice settings.[4][61] American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacokinetic monitoring. Am J Health Syst Pharm. 1998;55:1726-1727. Available at: https://www.ashp.org. Accessed February 17, 2026.American College of Clinical Pharmacology. Clinical pharmacology practice guidelines and position papers. Available at: https://www.accp1.org. Accessed February 17, 2026. Because medications have different volumes of distribution, appropriate dosing may depend on Vd to achieve adequate therapeutic drug concentrations, particularly when calculating loading doses and estimating the half-life (t1/2) of the drug. Understanding Vd helps bridge pharmacokinetic principles and clinical practice, making it valuable for the interprofessional healthcare team involved in patient care.